價(jià)格 | 詢價(jià) | ||
包裝 | 1支 | 1支 | 1支 |
最小起訂量 | 1支 |
發(fā)貨地 | 湖北 |
更新日期 | 2024-12-27 |
中文名稱:替組單抗 | 英文名稱:Research Grade Tacatuzumab (DHC01501) |
純度規(guī)格: PAGE:>95% | 產(chǎn)品類別: 藥物對(duì)照抗體 |
抗體名: Research Grade Tacatuzumab (DHC01501) | 靶點(diǎn): AFP, HPAFP |
宿主: Humanized | 適應(yīng)物種: Human |
克隆性: Monoclonal | 藥物對(duì)照抗體: Research Grade Tacatuzumab (DHC01501) |
Catalog No.
DHC01501
Host species
Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95% by SDS-PAGE.
Clonality
Monoclonal
Isotype
IgG1-kappa
Applications
Research Grade Biosimilar
Target
Alpha-fetoprotein, Alpha-1-fetoprotein, Alpha-fetoglobulin, AFP, HPAFP
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
P02771
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (4年) | 注冊(cè)資本 | 一千萬元人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生物化工,技術(shù)服務(wù) | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥3800 |
VIP3年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2024-12-20 | |
¥1580 |
VIP3年
|
上海滬震實(shí)業(yè)有限公司
|
2024-12-30 | |
¥700 |
武漢艾美捷科技有限公司
|
2024-12-25 |